7 reports

  • Vendor landscape

It begins in one eye and spreads to the other.

  • Eye Disease
  • Ophthalmic Solution
  • Akorn, Inc.
  • Alcon, Inc.
  • Allergan plc
  • Vendor landscape

Aazithromycin ##% ophthalmic solution is administered twice daily for two days, followed by once-daily administration for five days.

  • Anti-Infective
  • Eye Disease
  • Ophthalmic Solution
  • Akorn, Inc.
  • Alcon, Inc.
  • Scope of the report
  • Key vendor analysis

It blocks IL-## receptor signaling and prevents the binding of IL-## alpha and IL-## beta to the IL-## receptor.

  • Allergy Drug
  • Eye Disease
  • Ophthalmic Solution
  • Akorn, Inc.
  • Alcon, Inc.

The company develops, manufactures and markets contact lenses for contact lens wearers and the eye care professionals.

  • Ophthalmic Solution
  • Alcon, Inc.
  • Bausch & Lomb Incorporated
  • Carl Zeiss AG
  • Hoya Corporation

The company develops, manufactures and markets contact lenses for contact lens wearers and the eye care professionals.

  • Cataract Surgery Device
  • Eyewear
  • Ophthalmic Solution
  • Vitreoretinal Surgery Device
  • Hoya Corporation

Title Page No. ##.

  • Eye Disease
  • Eyewear
  • Ophthalmic Solution
  • Ophthalmology
  • Hoya Corporation

One unit refers to one microkeratome.

  • Ophthalmic Solution
  • United States
  • Company
  • Market Segment
  • Hoya Corporation